Survival outcomes. Kaplan-Meier curves illustrating time-to-event for the overall cohort and comparing axi-cel and liso-cel cohorts. (A) DOR curves for patients who achieved a CR or PR at first restaging after therapy. (B) PFS curves. (C) OS curves. IEC, immune effector cell.